Waverly Advisors LLC Has $6.64 Million Holdings in HealthEquity, Inc. $HQY

Waverly Advisors LLC increased its position in HealthEquity, Inc. (NASDAQ:HQY) by 20.5% in the second quarter, HoldingsChannel reports. The firm owned 73,569 shares of the company’s stock after acquiring an additional 12,514 shares during the period. Waverly Advisors LLC’s holdings in HealthEquity were worth $6,645,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in HealthEquity during the 2nd quarter valued at $1,018,621,000. California State Teachers Retirement System boosted its position in shares of HealthEquity by 8,679.7% in the second quarter. California State Teachers Retirement System now owns 8,832,754 shares of the company’s stock worth $797,774,000 after buying an additional 8,732,150 shares during the period. Wasatch Advisors LP grew its holdings in shares of HealthEquity by 10.5% during the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after buying an additional 757,801 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after buying an additional 5,671 shares in the last quarter. Finally, Westfield Capital Management Co. LP raised its position in HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after buying an additional 235,794 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HQY shares. Citizens Jmp increased their price objective on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, September 2nd. Finally, Raymond James Financial reiterated a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $111.87.

HealthEquity Stock Up 2.0%

HQY opened at $94.55 on Friday. The company has a market capitalization of $7.82 billion, a PE ratio of 34.13, a price-to-earnings-growth ratio of 1.46 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $107.62. The business has a 50-day moving average of $99.58 and a 200-day moving average of $89.18.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. The firm had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The company’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Adrian T. Dillon sold 7,632 shares of the stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,470 shares of the business’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the completion of the sale, the executive vice president directly owned 56,643 shares of the company’s stock, valued at $5,381,085. This represents a 4.18% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,456 shares of company stock worth $1,256,664 in the last 90 days. 1.60% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.